Standard of China Securities: Net profit in the first quarter of 2026 was 44,8218,000 yuan, an increase of 20.66% year-on-year.

Announcement of Sinopharm's financial report: In the first quarter of 2026, the operating income was 195 million yuan, a year-on-year increase of 17.54%. Net profit was 44.82 million yuan, a year-on-year increase of 20.66%.